| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2024 | 47 | $330M | +$10.6M | -$8.36M | +$2.23M | SCHD, MSFT, VZ, PM, SPYD | 13F-HR | 10/28/2024, 03:00 PM |
| Q2 2024 | 49 | $302M | +$38.9M | -$39.2M | -$307K | SCHD, MSFT, VZ, PM, SPYD | 13F-HR | 7/10/2024, 10:12 AM |
| Q1 2024 | 49 | $308M | +$19M | -$30.4M | -$11.4M | SCHD, MSFT, HDV, VZ, PEG | 13F-HR | 4/10/2024, 12:25 PM |
| Q4 2023 | 49 | $303M | +$2.55M | -$3.38M | -$836K | SCHD, MSFT, VZ, IBM, PM | 13F-HR | 1/12/2024, 09:52 AM |
| Q3 2023 | 48 | $286M | +$8.87M | -$7.76M | +$1.11M | SCHD, MSFT, PFE, VZ, PM | 13F-HR | 10/10/2023, 10:29 AM |
| Q2 2023 | 47 | $299M | +$25.7M | -$16.5M | +$9.16M | SCHD, MSFT, VZ, PFE, PM | 13F-HR | 7/11/2023, 04:14 PM |
| Q1 2023 | 45 | $294M | +$24.9M | -$24.3M | +$539K | SCHD, GSK, VZ, PFE, UL | 13F-HR | 4/21/2023, 01:49 PM |
| Q4 2022 | 44 | $297M | +$37.6M | -$34.6M | +$2.97M | SCHD, CSCO, GSK, VZ, PM | 13F-HR | 1/30/2023, 12:40 PM |
| Q3 2022 | 44 | $260M | +$26.1M | -$21.4M | +$4.7M | SCHD, XOM, CSCO, VZ, GSK | 13F-HR | 10/12/2022, 07:50 AM |
| Q2 2022 | 46 | $285M | +$28.4M | -$26.3M | +$2.11M | SCHD, XOM, GSK, CSCO, VZ | 13F-HR | 7/19/2022, 10:13 AM |
| Q1 2022 | 46 | $299M | +$21.8M | -$21.7M | +$14K | SCHD, XOM, GSK, MSFT, VZ | 13F-HR | 4/28/2022, 12:29 PM |
| Q4 2021 | 46 | $294M | +$25.4M | -$30.7M | -$5.3M | SCHD, GSK, XOM, HDV, MSFT | 13F-HR | 2/9/2022, 02:47 PM |
| Q3 2021 | 45 | $275M | +$20.5M | -$12.5M | +$8.03M | SCHD, XOM, PFE, BEN, HDV | 13F-HR | 10/15/2021, 02:59 PM |
| Q2 2021 | 46 | $276M | +$10.3M | -$13.6M | -$3.34M | SCHD, XOM, BEN, IBM, PFE | 13F-HR | 8/12/2021, 05:41 PM |
| Q1 2021 | 43 | $268M | +$11.3M | -$8.22M | +$3.13M | SCHD, BEN, USB, XOM, HDV | 13F-HR | 5/7/2021, 08:51 AM |
| Q4 2020 | 46 | $241M | +$19.2M | -$8.93M | +$10.3M | SCHD, PFE, HDV, BEN, USB | 13F-HR | 2/4/2021, 10:46 AM |
| Q3 2020 | 44 | $207M | +$41.7M | -$41.3M | +$422K | SCHD, PFE, VZ, IBM, HDV | 13F-HR | 11/4/2020, 05:53 PM |
| Q2 2020 | 46 | $203M | +$24.8M | -$19.9M | +$4.88M | SCHD, GPC, VYM, CVX, XOM | 13F-HR | 7/27/2020, 09:59 AM |
| Q1 2020 | 44 | $175M | +$46.8M | -$51.2M | -$4.36M | SCHD, VYM, PFE, T, GSK | 13F-HR | 5/5/2020, 08:44 AM |
| Q4 2019 | 45 | $224M | +$9.1M | -$5.83M | +$3.27M | SCHD, VYM, T, KO, PFE | 13F-HR | 2/6/2020, 12:00 PM |
| Q3 2019 | 46 | $209M | +$12.1M | -$10.2M | +$1.88M | SCHD, VYM, T, KO, UL | 13F-HR | 10/8/2019, 02:32 PM |
| Q2 2019 | 47 | $204M | +$14.8M | -$15.4M | -$578K | VYM, SCHD, PFE, UL, KO | 13F-HR | 8/5/2019, 01:10 PM |
| Q1 2019 | 46 | $203M | +$12.3M | -$9.72M | +$2.54M | VYM, PFE, PG, SCHD, PAYX | 13F-HR | 5/15/2019, 04:30 PM |
| Q4 2018 | 46 | $179M | +$5.09M | -$1.6M | +$3.49M | PFE, CSCO, VYM, PG, KO | 13F-HR | 2/5/2019, 01:41 PM |
| Q3 2018 | 45 | $196M | +$9.98M | -$8.16M | +$1.82M | CSCO, PFE, VYM, SCHD, CVX | 13F-HR | 11/2/2018, 10:28 AM |
| Q2 2018 | 45 | $182M | +$11.3M | -$8.96M | +$2.33M | CSCO, VYM, CVX, PFE, SCHD | 13F-HR | 8/6/2018, 01:37 PM |
| Q1 2018 | 47 | $179M | +$25.3M | -$25.6M | -$234K | VYM, CSCO, BTI, PFE, CVX | 13F-HR | 5/1/2018, 08:40 AM |
| Q4 2017 | 45 | $187M | +$19M | -$19M | -$2.49K | VYM, BTI, CVX, CSCO, T | 13F-HR | 2/7/2018, 08:23 AM |
| Q3 2017 | 46 | $176M | +$17.2M | -$14.5M | +$2.76M | BA, VYM, BTI, CVX, PFE | 13F-HR | 11/8/2017, 02:39 PM |
| Q2 2017 | 47 | $165M | +$8.48M | -$6.08M | +$2.4M | BA, VYM, CVX, PFE, SCHD | 13F-HR | 8/2/2017, 02:40 PM |
| Q1 2017 | 47 | $161M | +$5.75M | -$1.86M | +$3.89M | BA, VYM, T, CVX, CSCO | 13F-HR | 5/8/2017, 12:55 PM |
| Q4 2016 | 46 | $153M | +$3.05M | -$2.99M | +$61.3K | VYM, CVX, T, BA, SCHD | 13F-HR | 2/8/2017, 03:27 PM |
| Q3 2016 | 44 | $152M | +$9.69M | -$5.43M | +$4.26M | VYM, T, CVX, CSCO, PFE | 13F-HR | 10/12/2016, 02:48 PM |
| Q2 2016 | 44 | $148M | +$12M | -$12M | -$6.12K | VYM, WEC, T, CVX, PFE | 13F-HR | 7/21/2016, 10:30 AM |
| Q1 2016 | 43 | $140M | +$16.6M | -$15.6M | +$988K | VYM, WEC, T, CVX, PM | 13F-HR | 4/5/2016, 01:31 PM |
| Q4 2015 | 43 | $132M | +$6.01M | -$5.45M | +$563K | PG, VYM, WEC, MCD, CVX | 13F-HR | 2/8/2016, 02:26 PM |
| Q3 2015 | 43 | $124M | +$11.5M | -$8.81M | +$2.68M | WEC, PG, PFE, T, KO | 13F-HR | 10/22/2015, 12:16 PM |
| Q2 2015 | 42 | $127M | +$13.7M | -$14.8M | -$1.01M | AAPL, PG, PFE, T, OXY | 13F-HR | 8/11/2015, 12:43 PM |
| Q1 2015 | 43 | $132M | +$14.1M | -$14.7M | -$623K | AAPL, PG, PFE, WEC, SYY | 13F-HR | 4/23/2015, 11:39 AM |
| Q4 2014 | 45 | $136M | +$21.3M | -$20.6M | +$704K | LMT, PG, AAPL, WEC, SYY | 13F-HR | 1/27/2015, 05:08 PM |
| Q3 2014 | 45 | $133M | +$6.66M | -$6.65M | +$11.7K | LMT, PG, CSCO, INTC, MSFT | 13F-HR | 10/20/2014, 01:29 PM |
| Q2 2014 | 47 | $133M | +$12.5M | -$11.4M | +$1.05M | LMT, INTC, PG, TTE, CSCO | 13F-HR | 8/11/2014, 02:04 PM |
| Q1 2014 | 52 | $129M | +$13.8M | -$12.4M | +$1.4M | LMT, PG, TTE, PFE, POT | 13F-HR | 4/14/2014, 03:46 PM |
| Q4 2013 | 94 | $125M | $0 | $0 | LMT, PG, PFE, TTE, DHS | 13F-HR | 2/4/2014, 04:21 PM |